2025 Neuro-oncology Reading List

Reading List

Please click below to access the 2025 Neuro-oncology reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Successfully treat tumor-associated complications including seizures and venous thromboembolism
• Apply the results gathered from prospective clinical trials in the management of adult and pediatric primary brain tumor patients
• Identify patients suitable for treatment with IDH inhibitors
• Discuss the application of novel targeted agents to the treatment of adult and pediatric primary brain tumors

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2025 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Neuro-oncology Certification Examination Committee Contributors

Christian Grommes, MD, Chair, Memorial Sloan Kettering Cancer Center 
Disclosures: Receive compensation from Roche – Consulting, BTG – Consulting, Curis – Consulting, and Ono- Consulting; receive compensation for serving on speakers bureau for Ono and Curis. 

Andrea Wasilewski, MD, Vice Chair, Givens Brain Tumor Center 
Disclosures: Received compensation for serving as a consultant for Novocure- consultant, digital opinion leader, and for work with Servier- consultant, advisory board member. 

David M. Cachia, MD, UMass Memorial Medical Center 
Disclosures: Received consultation compensation from Guidepoint Global LLC, Dedham Group, Gerson Lehrman Group, and Aptitude Health.

Cynthia J. Campen, MD, Stanford Medicine Children’s Health 
Disclosures: Received compensation for Alexion speakers bureau at 2022 Society for Neuro-oncology on Diagnosis and Treatment of NF1-Associated Optic Pathway Glioma; received research support from non-profit, philanthropic organization has funded my research - The Greathouse Family Foundation. 

Ashley P. Ghiaseddin, MD, University of Florida 
Disclosures: Received consulting compensation from Monteris Medical, Neosoma, Investor Guidepoint Global, and Aptitude Health; Received compensation for serving on advisory board for Alexion Pharmaceuticals, Servier, and Ono Pharma USA; Held Personal Stock in Viatris Inc. from 2022-2023; Have Stock Options in Neosoma.

Douglas E. Ney, MD, University of Colorado – Anschutz Medical Campus 
Disclosures: Received research support from Orbus Therapeutics, Denovo Biopharma, and Cantex Pharmaceuticals. 

Jerome J. Graber, MD, MPH, Alvord Brain Tumor Center 
Disclosures: Served as a compensated consultant for the American Academy of Neurology, Servier, M3, and Guidepoint; Served as an expert witness for Dickie McCamey, Attorneys at Law; non-compensated work for American Academy of Neurology on the Question of the Day app, NeuroSAE, and Continuum.

Gurcharanjeet Kaur, MD, Columbia University Irving Medical Center 
Disclosures: Paid speaker for Alexion AstraZeneca Rare Disease; receive compensation for serving as consultant and on the Advisory board for Alexion AstraZeneca Rare disease. 

Maria J. MacDonald, MD, London Health Sciences Ctr, Univ. of Western Ontario 
Disclosures: Received research support from Brain Cancer Canada; grant of $50,000 for a pediatric glioma study. 

Lauren Schaff, MD, Memorial Sloan Kettering Cancer Center 
Disclosures: Received compensation as a consultant from ONO Servier; received compensation for serving on advisory board for BTG, plc; received research support from BTG, plc, and Merck; Patent pending for use of low-dose glucarpidase. 

Roy E. Strowd, III, MD, Wake Forest Baptist Health 
Disclosures: Receives compensation as a consultant for Monteris Medical, Novocure, and Lecturio; receives compensation from American Academy of Neurology Institute for serving as editor for Neurology: Education and associate editor and section editor for the AAN’s Resident & Fellow Section of Neurology; receives research support from IAMSE, National Institute of Health; receives royalties from Elsevier. 

Lauryn Hemminger, MD, University of Rochester Medical Center 
Disclosures: Nothing to disclose. 

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326